F.D.A. Panel Splits on Whether to Approve New Diabetes Drug

The advisory committee voted 8-8 on approving the drug, to be called Zynquista, which would be the first oral medication for people with Type 1 diabetes.

Source: NYT Health - January 17, 2019 Category: Consumer Health News Authors: KATIE THOMAS Tags: Food and Drug Administration Lexicon Pharmaceuticals Inc Sanofi SA Drugs (Pharmaceuticals) Diabetes Source Type: news